Thibault P K, Wlodarczyk J
J Dermatol Surg Oncol. 1994 Oct;20(10):684-6. doi: 10.1111/j.1524-4725.1994.tb00453.x.
Postsclerotherapy pigmentation is a common sequela of sclerotherapy to varicose and telangiectatic leg veins. This pigmentation is thought to be due to hemosiderin deposition in the dermis. A preliminary study indicated that serum ferritin was a good indicator of susceptibility to postsclerotherapy pigmentation.
To clarify the relationship between serum ferritin and postsclerotherapy pigmentation using a prospective study.
Serum ferritin levels were taken from 233 consecutive patients prior to commencement of sclerotherapy. Patients were assessed clinically for the presence of pigmentation at 3, 6, and 12 months.
There was a linear relationship between pretreatment serum ferritin level and the occurrence of pigmentation at each posttreatment assessment date.
The results confirm a relationship between serum ferritin levels and postsclerotherapy pigmentation. This indicates that a significant predisposing factor to the development of persistent postsclerotherapy pigmentation is a high level of total body iron stores.
硬化治疗后色素沉着是下肢静脉曲张和毛细血管扩张症硬化治疗常见的后遗症。这种色素沉着被认为是由于含铁血黄素沉积于真皮所致。一项初步研究表明,血清铁蛋白是硬化治疗后色素沉着易感性的良好指标。
采用前瞻性研究阐明血清铁蛋白与硬化治疗后色素沉着之间的关系。
在233例连续接受硬化治疗的患者开始治疗前检测血清铁蛋白水平。在治疗后3个月、6个月和12个月对患者进行色素沉着临床评估。
治疗前血清铁蛋白水平与各治疗后评估日期色素沉着的发生呈线性关系。
结果证实血清铁蛋白水平与硬化治疗后色素沉着之间存在关联。这表明全身铁储存水平高是导致持续性硬化治疗后色素沉着的一个重要易感因素。